Cantor Fitzgerald downgraded shares of Envision Healthcare Corporation (NYSE:EVHC) from an overweight rating to a neutral rating in a research report report published on Wednesday, MarketBeat reports. They currently have $30.00 target price on the stock.
“3Q17 weak, 2017-18 outlook dims. EVHC’s revenue was in line with our expectations, as was its ambulatory services business, but Physician Services earnings were 5-10% below our estimates, partly because of hurricanes in September, but also disappointing utilization and slower new business development.”,” the firm’s analyst commented.
A number of other research analysts have also issued reports on EVHC. Zacks Investment Research raised Envision Healthcare Corporation from a sell rating to a hold rating in a report on Friday, August 11th. Mizuho lowered their target price on Envision Healthcare Corporation from $65.00 to $57.00 and set a neutral rating on the stock in a report on Wednesday, August 9th. BidaskClub lowered Envision Healthcare Corporation from a sell rating to a strong sell rating in a report on Thursday, August 17th. Robert W. Baird reaffirmed a buy rating and set a $70.00 target price on shares of Envision Healthcare Corporation in a report on Tuesday, October 17th. Finally, SunTrust Banks, Inc. set a $55.00 target price on Envision Healthcare Corporation and gave the stock a buy rating in a report on Sunday, October 15th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average target price of $49.21.
Envision Healthcare Corporation (NYSE EVHC) traded down $0.99 during trading hours on Wednesday, reaching $27.04. The company had a trading volume of 4,795,013 shares, compared to its average volume of 4,320,000. The company has a current ratio of 3.01, a quick ratio of 2.82 and a debt-to-equity ratio of 0.89. The firm has a market capitalization of $3.29 billion, a price-to-earnings ratio of 8.41, a P/E/G ratio of 0.58 and a beta of 0.69. Envision Healthcare Corporation has a 1 year low of $26.56 and a 1 year high of $74.75.
Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare Corporation had a positive return on equity of 4.88% and a negative net margin of 6.39%. Envision Healthcare Corporation’s revenue was up 142.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.13 earnings per share. equities analysts anticipate that Envision Healthcare Corporation will post 3.14 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Cantor Fitzgerald Lowers Envision Healthcare Corporation (EVHC) to Neutral” was first published by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.com-unik.info/2017/11/04/cantor-fitzgerald-lowers-envision-healthcare-corporation-evhc-to-neutral.html.
Envision Healthcare Corporation announced that its Board of Directors has approved a share buyback program on Monday, September 18th that allows the company to buyback $250.00 million in shares. This buyback authorization allows the company to purchase up to 4.5% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its stock is undervalued.
A number of hedge funds and other institutional investors have recently made changes to their positions in EVHC. Commonwealth Bank of Australia boosted its position in Envision Healthcare Corporation by 24.3% during the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after acquiring an additional 410 shares during the period. LMR Partners LLP bought a new position in shares of Envision Healthcare Corporation in the 2nd quarter valued at approximately $205,000. OLD Mutual Customised Solutions Proprietary Ltd. raised its stake in shares of Envision Healthcare Corporation by 54.5% in the 1st quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 3,401 shares of the company’s stock valued at $209,000 after acquiring an additional 1,200 shares in the last quarter. Palisade Capital Management LLC NJ bought a new position in shares of Envision Healthcare Corporation in the 3rd quarter valued at approximately $229,000. Finally, Cutter & CO Brokerage Inc. raised its stake in shares of Envision Healthcare Corporation by 11.1% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock valued at $230,000 after acquiring an additional 367 shares in the last quarter.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
What are top analysts saying about Envision Healthcare Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Corporation and related companies.